What insurance does a US lab need to receive specimens from outside the United States?

A laboratory taking foreign specimens is usually still performing the testing in the United States, which makes people assume nothing has changed. What has changed is the location of the person who may sue, the location of the entity that collected the sample, and the journey the sample takes.

Each of those maps to a different part of the programme, and only the first is a coverage territory question.

The relevant test is the same one that governs products cover: where the services were performed, and where liability may be determined. A policy limited to suits brought in the United States and Canada is a real constraint once you take work referred from a foreign clinic or sponsor.

Read the coverage territory definition on the professional liability or errors and omissions form specifically. It is not always the same wording as the general liability territory, and assuming they match is a common mistake.

When a clinic, phlebotomy provider, or partner lab abroad collects the sample, they sit upstream of your result. Collection and handling errors reach your report, and a claimant will typically name the laboratory whose name is on it.

That makes their insurance your concern. Verifying the cover of an entity in another market is harder than domestically: limits are stated in different currencies, local forms are narrower, and a certificate may not carry the endorsement language you would expect. Treat it as a vetting exercise, which is covered in the vendor certificate review entry.

Importing human or infectious biological material into the United States can require a federal permit, and shipments are subject to packaging and documentation rules for the category of material being moved. A shipment held, seized, or spoiled at the border is a loss, and it is not a professional liability loss.

Cover for the material in transit and for temperature excursion sits with cargo, transit, and equipment breakdown rather than with the professional lines. Labs that have built good professional liability programmes frequently have nothing addressing this.

The common entry points are a sponsor sending samples from a trial site abroad, a partnership with an overseas clinic, and a direct-to-consumer or telehealth channel that quietly begins accepting non-US orders.

The last of those is worth a specific check, because nobody experiences it as a decision to enter a foreign market.